{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:21:54Z","timestamp":1759191714219,"version":"3.44.0"},"reference-count":23,"publisher":"Sociedade Brasileira de Pneumologia e Tisiologia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bras Pneumol."],"abstract":"<jats:p>Objective: To evaluate the prevalence of alpha-1 antitrypsin (AAT) variants through SERPINA1 genotyping in patients with non-cystic fibrosis bronchiectasis, and assess their clinical, functional and radiological characteristics. AAT deficiency is underdiagnosed, and an etiology to be considered when evaluating bronchiectasis. Methods: A cross-sectional study was conducted at an outpatient clinic focused on bronchiectasis in a tertiary hospital. Data from patients followed between 2005 and 2023 were collected. Genotyping for AAT was performed. Demographic, clinical, pulmonary function tests, serum AAT levels and chest CT data were analyzed. Results: A total of 136 patients were included, predominantly female (72.1%), with a median age of 56.6 years. The prevalence of SERPINA1 gene mutations was 25.7% (n=35). Among the detected variant genotypes were Pi*MS (15.4%), Pi*MZ (5,1%), Pi*SS (1,5%), Pi*ZZ (1,5%), Pi*MI (0,7%), Pi*SZ (0,7%) and Pi*ZMMalton (0,7%). When comparing patients with and without SERPINA1 mutations, significant differences were observed in AAT serum levels, emphysema type (panlobular) and distribution (diffuse and lower-lobe predominant). No other clinical, microbiological, functional or radiological differences were found, including emphysema presence or absence. Notably, 16 (45.7%) of individuals carrying SERPINA1 mutations exhibited normal serum AAT levels. Conclusions: AAT variants are not uncommon among patients with bronchiectasis. Presence of panlobular, diffuse or lower-lobe predominant emphysema should prompt AATD diagnostic consideration. However, the absence of emphysema does not exclude the diagnosis. Moreover, SERPINA1 variants may occur along with normal AAT serum levels. Clinicians should consider genotyping in patients with normal AAT levels, particularly when bronchiectasis remains unexplained.<\/jats:p>","DOI":"10.36416\/1806-3756\/e20250181","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:06:24Z","timestamp":1759172784000},"page":"e20250181","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of SERPINA1 mutations in a bronchiectasis cohort: implications of extended screening for alpha-1 antitrypsin deficiency"],"prefix":"10.36416","author":[{"given":"Caroline","family":"Souza Sokoloski1","sequence":"first","affiliation":[{"name":"1. Servi\u00e7o de Pneumologia, Complexo Hospital de Cl\u00ednicas, Universidade Federal do Paran\u00e1, Curitiba (PR) Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariane","family":"Gon\u00e7alves Martynychen Canan1","sequence":"additional","affiliation":[{"name":"1. Servi\u00e7o de Pneumologia, Complexo Hospital de Cl\u00ednicas, Universidade Federal do Paran\u00e1, Curitiba (PR) Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cleverson","family":"Alex Leit\u00e3o2","sequence":"additional","affiliation":[{"name":"2. Servi\u00e7o de Radiologia, Complexo Hospital de Cl\u00ednicas, Universidade Federal do Paran\u00e1, Curitiba (PR) Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Mueller Storrer1","sequence":"additional","affiliation":[{"name":"1. Servi\u00e7o de Pneumologia, Complexo Hospital de Cl\u00ednicas, Universidade Federal do Paran\u00e1, Curitiba (PR) Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22288","published-online":{"date-parts":[[2025,9,19]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1.           Miravitlles M, Dirksen A, Ferrarotti I, Koblizek V, Lange P, Mahadeva R, et al. European Respiratory Society statement: Diagnosis and treatment of pulmonary disease in Alfa1-antitrypsin deficiency. Eur Respir J. 2017;50(5):1700610. https:\/\/doi.org\/10.1183\/13993003.00610-2017","DOI":"10.1183\/13993003.00610-2017"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2.           Stockley RA, Parr DG. Antitrypsin deficiency; still more to learn about the lung after 60 years. ERJ Open Res. 2024;10(4):00139-2024. https:\/\/doi.org\/10.1183\/23120541.00139-2024","DOI":"10.1183\/23120541.00139-2024"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3.           Feitosa PHR, Castellano MVCO, Costa CHD, Cardoso ADRO, Pereira LFF, Fernandes FLA, et al. Recommendations for the diagnosis and treatment of alpha-1 antitrypsin deficiency. J Bras Pneumol. 2024;50(5): e20240235. https:\/\/doi.org\/10.36416\/1806-3756\/e20240235","DOI":"10.36416\/1806-3756\/e20240235"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4.           Stockley RA, Pye A, De Soyza J, Turner AM, Miravitlles M. The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCO. Orphanet J Rare Dis. 2023;18(1):1-8. https:\/\/doi.org\/10.1186\/s13023-023-02830-2","DOI":"10.21203\/rs.3.rs-2612082\/v1"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5.           Soyza J De, Ellis BP, Newnham M, Rickard L, Turner MAM. Bronchiectasis Occurs Independently of Chronic Obstructive Pulmonary Disease in Alpha-1 Antitrypsin Deficiency. Chronic Obstr Pulm Dis. 2024;11(5):507-514. https:\/\/doi.org\/10.15326\/jcopdf.2024.0526","DOI":"10.15326\/jcopdf.2024.0526"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6.           Pereira MC, Athanazio RA, Dalcin PTR, Figueiredo MRF, Gomes M, Freitas CG, et al. Brazilian consensus on non-cystic fibrosis bronchiectasis. J Bras Pneumol. 2019;45(4):e20190122. https:\/\/doi.org\/10.1590\/1806-3713\/e20190122","DOI":"10.1590\/1806-3713\/e20190122"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7.           Lonni S, Chalmers JD, Goeminne PC, Mcdonnell MJ, Dimakou K, De Soyza A, et al. Etiology of Non-Cystic Fibrosis Bronchiectasis in Adults and Its Correlation to Disease Severity. Ann Am Thorac Soc. 2015;12(12):1764-70. https:\/\/doi.org\/10.1513\/AnnalsATS.201507-472OC","DOI":"10.1513\/annalsats.201507-472oc"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8.           Olveira C, Padilla A, Mart\u00ednez-Garc\u00eda M\u00c1, De La Rosa D, Gir\u00f3n RM, Vendrell M, et al. Etiology of Bronchiectasis in a Cohort of 2047 Patients. An Analysis of the Spanish Historical Bronchiectasis Registry. Arch Bronconeumol. 2017;53(7):366-374. https:\/\/doi.org\/10.1016\/j.arbres.2016.12.003","DOI":"10.1016\/j.arbr.2017.05.005"},{"key":"ref8","unstructured":"9.           Orphanet Report Series [homepage on the Internet]. Paris: Orphanet; c2024. Prevalence and incidence of rare diseases: Bibliographic data. [Adobe Acrobat doc. 194p.].. Available from: http:\/\/www.orpha.net\/orphacom\/cahiers\/docs\/GB\/Prevalence_of_rare_diseases_by_alphabetical_list.pdf"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10.        Jardim JR, Casas-Maldonado F, Fernandes FLA, Castellano MVCO, Torres-Dur\u00e1n M, Miravitlles M. Update on and future perspectives for the diagnosis of alpha-1 antitrypsin deficiency in Brazil. J Bras Pneumol. 2021;47(3):e20200380. https:\/\/doi.org\/10.36416\/1806-3756\/e20200380","DOI":"10.36416\/1806-3756\/e20200380"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11.        Russo R, Zillmer LR, Nascimento OA, Manzano B, Ivanaga IT, Fritscher L, et al. Prevalence of alpha-1 antitrypsin deficiency and allele frequency in patients with COPD in Brazil. J Bras Pneumol. 2016;42(5):311-6. https:\/\/doi.org\/10.1590\/S1806-37562015000000180","DOI":"10.1590\/s1806-37562015000000180"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12.        Ara\u00fajo D, Shteinberg M, Aliberti S, Goeminne PC, Hill AT, Fardon T, et al. Standardised classification of the aetiology of bronchiectasis using an objective algorithm. Eur Respir J. 2017;50(6):3-6. https:\/\/doi.org\/10.1183\/13993003.01289-2017","DOI":"10.1183\/13993003.01289-2017"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13.        Miravitlles M, Anzueto A, Barrecheguren M. Nine controversial questions about augmentation therapy for alpha-1 antitrypsin deficiency: a viewpoint. Eur Respir Rev. 2023;32(170):1-12. https:\/\/doi.org\/10.1183\/16000617.0170-2023","DOI":"10.1183\/16000617.0170-2023"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14.        Eden E, Choate R, Barker A, Addrizzo-Harris D, Aksamit TR, Daley CL, et al. The Clinical Features of Bronchiectasis Associated with Alpha-1 Antitrypsin Deficiency, Common Variable Immunodeficiency and Primary Ciliary Dyskinesia--Results from the U.S. Bronchiectasis Research Registry. Chronic Obstr Pulm Dis. 2019;6(2):145-153. https:\/\/doi.org\/10.15326\/jcopdf.6.2.2018.0156","DOI":"10.15326\/jcopdf.6.2.2018.0156"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15.        Aliberti S, Gramegna A, Seia M, Malvestiti F, Mantero M, Sotgiu G, et al. Alpha1-Antitrypsin Inherited Variants in Patients With Bronchiectasis. Arch Bronconeumol. 2023;59(6):401-2. https:\/\/doi.org\/10.1016\/j.arbres.2023.01.004","DOI":"10.1016\/j.arbres.2023.01.004"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16.        Carreto L, Morrison M, Donovan J, Finch S, Tan GL, Fardon T, et al. Utility of routine screening for alpha-1 antitrypsin deficiency in patients with bronchiectasis. Thorax. 2020;75:592-3. https:\/\/doi.org\/10.1136\/thoraxjnl-2019-214195","DOI":"10.1136\/thoraxjnl-2019-214195"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17.        Cuvelier A, Muir JF, Hellot MF, Benhamou D, Martin JP, B\u00e9nichou J, et al. Distribution of \u03b11-antitrypsin alleles in patients with bronchiectasis. Chest. 2000;117(2):415-9. https:\/\/doi.org\/10.1378\/chest.117.2.415","DOI":"10.1378\/chest.117.2.415"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18.        Hill AT, Sullivan AL, Chalmers JD, De Soyza A, Elborn S, Floto RA, et al. BTS Guidelines for Bronchiectasis 2018. Thorax. 2019;74(1):1-69. https:\/\/doi.org\/10.1136\/thoraxjnl-2018-212468","DOI":"10.1136\/thoraxjnl-2018-212468"},{"key":"ref18","unstructured":"19.        Stoller JK, Hupertz V, Aboussouan LS. Alpha-1 Antitrypsin Deficiency. 2006 Oct 27 [updated 2023 Jun 1]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993\u20132025. PMID: 20301692."},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20.        Franciosi AN, Fraughen D, Carroll TP, McElvaney NG. Alpha-1 antitrypsin deficiency: clarifying the role of the putative protective threshold. Eur Respir J. 2022;59(2):1-12. https:\/\/doi.org\/10.1183\/13993003.01410-2021","DOI":"10.1183\/13993003.01410-2021"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21.        Long MB, Chotirmall SH, Shteinberg M, Chalmers JD. Review Rethinking bronchiectasis as an inflammatory disease. Lancet Respir. 2024;2600(24):1-14. https:\/\/doi.org\/10.1016\/S2213-2600(24)00176-0","DOI":"10.1016\/s2213-2600(24)00176-0"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22.        Bai X, Bai A, Honda JR, Eichstaedt C, Musheyev A, Feng Z, et al. Alpha-1-Antitrypsin Enhances Primary Human Macrophage Immunity against Non-tuberculous Mycobacteria. Front Immunol. 2019;10:1417. https:\/\/doi.org\/10.3389\/fimmu.2019.01417","DOI":"10.3389\/fimmu.2019.01417"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23.        De Smet S, Dierick J, Steyaert S, Schurgers M, Van Steenkiste C, Loof S. Alfa-1-antitrypsin deficiency: a predisposing factor leading to invasive infec-tions? Infect Dis (Auckl). 2020;52(2):130-4. https:\/\/doi.org\/10.1080\/23744235.2019.1690163","DOI":"10.1080\/23744235.2019.1690163"}],"container-title":["Jornal Brasileiro de Pneumologia"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:06:25Z","timestamp":1759172785000},"score":1,"resource":{"primary":{"URL":"https:\/\/jornaldepneumologia.com.br\/details\/4162\/en-US"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":23,"URL":"https:\/\/doi.org\/10.36416\/1806-3756\/e20250181","relation":{},"ISSN":["1806-3756"],"issn-type":[{"value":"1806-3756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,19]]}}}